Human anti-alpha-synuclein antibodies
US10703808B2 · kind B2 · utility
0Cited by
32References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 2018 |
| Grant date | Jul 7, 2020 |
| Priority date | — |
| Expiry date | Jan 9, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2835
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are novel human α-synuclein-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for α-synuclein are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for α-synuclein targeted immunotherapy and diagnosis, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.